The largest database of trusted experimental protocols

H37ra atcc 25177

Sourced in United States

H37Ra (ATCC 25177) is a laboratory strain of Mycobacterium tuberculosis, the causative agent of tuberculosis. This strain is a non-virulent variant of the virulent H37Rv strain and is commonly used in research settings for the study of tuberculosis.

Automatically generated - may contain errors

6 protocols using h37ra atcc 25177

1

Isolation of CD4+ T-cells from Mtb-Infected Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Virulent Mtb strain H37Rv ATCC 27294 and the avirulent strain H37Ra ATCC 25177 were purchased from American Type Culture Collection (ATCC, Manassas, VA). All mycobacteria were provided from the International Tuberculosis Research Center (ITRC, Changwon, Gyeongsangnam-do, South Korea). These strains were cultured in Middlebrook 7H9 broth (Difco Laboratories, Detroit, MI) supplemented with 0.02% glycerol and 10% (vol/vol) oleic acid-albumin-dextrose-catalase (OADC, Becton Dickinson, Sparks, MD) for 25–28 days at 37°C. Age- and sex-matched C57BL/6 mice were infected with Mtb H37Ra, and the mycobacteria preparation protocol was performed as previously described [29 (link)]. Briefly, 6-week-old mice per group were intravenous initial infectious dose with 107 CFU Mtb H37Ra. The infected mice were euthanized at 6 weeks after infection to analyze immune responses. CD4+ T-cells were isolated from the spleens of H37Ra-infected mice using a MACS column.
+ Open protocol
+ Expand
2

Cultivation of Mycobacterium species

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mtb H37Rv (ATCC 27294) and H37Ra (ATCC 25177) were purchased from the American Type Culture Collection (ATCC, Manassas, VA, USA). M. bovis BCG (Tokyo strain) was provided by the Korean Institute of Tuberculosis (KIT). Mycobacteria were grown in Middlebrook 7H9 medium with 0.2% glycerol, 0.05% Tween-80 (Sigma, St. Louis, MO, USA), and 10% OADC (oleic acid, albumin, dextrose, and catalase; BD Biosciences, San Jose, CA, USA).
+ Open protocol
+ Expand
3

Growth of M. tuberculosis Strains

Check if the same lab product or an alternative is used in the 5 most similar protocols

M. tuberculosis H37Rv (ATCC 27294) and H37Ra (ATCC 25177) used in this study were purchased from American Type Culture Collection (Manassas, VA, USA). M. tuberculosis H37Rv and H37Ra were grown in Middlebrook 7H9 broth (Difco Laboratories, Detroit, MI, USA) supplemented with 10% (v/v) oleic acid/albumin/dextrose/catalase enrichment (Becton–Dickinson and Company, Sparks, MD, USA) and 0.05% (v/v) Tween 80 (Sigma–Aldrich Chemical, St. Louis, MO, USA) to the log phase at 37 °C for 4–5 weeks on shaking incubation of 120 r/min.
+ Open protocol
+ Expand
4

Mycobacterial Strain Acquisition and Preparation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mtb H37Rv (ATCC 27294) and H37Ra (ATCC 25177) were purchased from American Type Culture Collection (ATCC, Manassas, VA), and Mtb HN878 was obtained from the strain collections of the International Tuberculosis Research Center (ITRC, Changwon, Gyeongsangnam-do, South Korea). M. bovis BCG (Pasteur strain 1173P2) was kindly provided by Dr. Brosch at the Pasteur Institute (Paris, France). All mycobacteria used in this study were prepared as described previously [25 (link)].
+ Open protocol
+ Expand
5

Preparation of Mycobacterium tuberculosis Strains

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mtb H37Rv (ATCC 27294) and H37Ra (ATCC 25177) were purchased from American Type Culture Collection (ATCC, Manassas, VA), and the Mtb K strain was obtained from the strain collections at the Korean Institute of Tuberculosis (Korean National Tuberculosis Association, Seoul, Republic of Korea). All strains were cultured in Middlebrook 7H9 broth (Difco Laboratories, Detroit, MI) supplemented with 0.02% glycerol and 10% (vol/vol) oleic acid-albumin-dextrose-catalase (OADC, Becton Dickinson, Sparks, MD) for 28 days at 37°C. Single cell suspensions of each strain were prepared as previously described with slight modifications. Briefly, mycobacterial cells grown in OADC-supplemented 7H9 broth were harvested by centrifugation at 10,000 × g for 20 min and washed three times in phosphate-buffered saline (PBS) (pH 7.2). The pellets were homogenized using an overhead stirrer (Wheaton Instrument, Millville, NJ) for 1 min on ice to minimize bacterial clumping. The homogenized mycobacterial cells were passed through an 8 μm filter (Millipore Corp., Bedford, MA). The predominant presence of single cells in the final preparation was confirmed by acid-fast staining. The seed lots of each strain were stored in small aliquots at -80°C until use. The CFUs per 1 ml of the seed lots were measured by a viable counting assay on 7H10 agar plates.
+ Open protocol
+ Expand
6

Mycobacterium tuberculosis Strains Acquisition

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mtb H37Rv (ATCC 27294) and H37Ra (ATCC 25177) were purchased from the American Type Culture Collection (ATCC) (Manassas, VA, USA). The Mtb K strain (from the Beijing lineage, which is predominant in Korea77 (link)) was obtained from the strain collection of the Korean Institute of Tuberculosis (Osong, Chungchungbuk-do, Republic of Korea). The Mtb HN878, Erdman and M2 strains were obtained from the strain collection of the International Tuberculosis Research Center (Changwon, Gyeongsangnam-do, Republic of Korea). The BCG vaccine (Pasteur 1173P2) was kindly provided by Dr. Brosch from the Pasteur Institute (Paris, France). All Mtb strains used in this study were cultured and prepared as previously described78 (link).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!